MedDataX Logo

Renal Doppler in Pediatric Patients With Idiopathic Nephrotic Syndrome

NCT ID: NCT05912673

Last Updated: 2024-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-28

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of the renal resistive index in pediatric patient with idiopathic nephrotic syndrome to detect steroid resistance and to use it as a prognostic instrument of the progression of the disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic Syndrome

NCT06622915

Nephrotic Syndrome
RECRUITING NA

Electrocardiograph Changes and Holter Abnormalities in Children With Predialytic Chronic Kidney Disease

NCT05726071

Predialytic Chronic Kidney Disease
UNKNOWN

Steroid Treatment of Idiopathic Nephrotic Syndrome

NCT01386957

Nephrotic Syndrome
COMPLETED

Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease

NCT00208676

Congenital Heart Defects
TERMINATED

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

NCT06792448

Nephrotic Syndrome Steroid-Dependent Nephrotic Syndrome Steroid-Resistant Nephrotic Syndrome in Children +5 more
NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Renal Doppler will be done for all children in supine and lateral positions using Toshiba Aplio ultrasound machine and renal resistive index will be measured (peak systolic velocity- end diastolic velocity/ peak systolic velocity) at diagnosis, after one month, 3 months and 6months, in which these values will be obtained by the ultrasound machine based on the computer algorithm. Also the kidneys will be scanned firstly for length, width, cortical thickness and echogenicity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nephrotic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

renal doppler

Toshiba Aplio ultrasound machine and renal resistive index will be measured (peak systolic velocity- end diastolic velocity/ peak systolic velocity

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric patients with primary nephrotic syndrome aged from 1 to 18 years

Exclusion Criteria

* \- Patients with congenital nephrotic syndrome.
* Patients with secondary causes of nephrotic syndrome.
Minimum Eligible Age

1 Year

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sara Mabrouk Elghoul

Tanta, Stadium Street

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara Mabrouk Mohamed Elghoul, MD

Role: PRINCIPAL_INVESTIGATOR

Tanta University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sara Mabrouk Mohamed Elghoul

Tanta, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36264PR25/1/23

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome.
NCT07071597 ACTIVE_NOT_RECRUITING
B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient
NCT00330811 COMPLETED
Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome
NCT07194213 ACTIVE_NOT_RECRUITING
Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome
NCT02382575 UNKNOWN PHASE4
Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial.
NCT06079788 RECRUITING PHASE3
Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester
NCT01201486 COMPLETED
Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
NCT01497054 COMPLETED
Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
NCT04048161 COMPLETED PHASE4
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
NCT04222101 TERMINATED NA
Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels
NCT04508036 UNKNOWN
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome
NCT00238810 COMPLETED
Simplified Diagnostic Algorithm for Evaluation of Neonates With Prenatally Detected Hydronephrosis
NCT01330511 COMPLETED
Fontan Associated Liver Disease
NCT03914196 ACTIVE_NOT_RECRUITING
Predictors of Steroid Response in Childhood Nephrotic Syndrome
NCT06130631 NOT_YET_RECRUITING
Eisenmenger's Syndrome in Adults With CHD
NCT00266903 COMPLETED
Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome
NCT06325098 RECRUITING NA
Effect of Domperidone on QT Interval in Premature Infants
NCT00238056 COMPLETED PHASE2
Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome
NCT01609426 COMPLETED
Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children
NCT04043858 UNKNOWN NA
End-organ Pathology in Childhood Essential Hypertension
NCT00005180 COMPLETED
Incidence of Hypertrophic Cardiomyopathy in Infants of Diabetic Mothers Attending in NICU at Assiut University Children Hospital During One Year
NCT06048562 COMPLETED NA
The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the Aorta
NCT05880576 ENROLLING_BY_INVITATION
Validation of Cardiac Magnetic Resonance Sequences in Patients With Single Ventricles
NCT04017494 UNKNOWN
DeHydration: Assessing Kids Accurately
NCT02007733 COMPLETED
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
NCT03326037 UNKNOWN